Researchers have discovered a new method to boost the body's natural ability to fight respiratory viruses, including ...

Data from Phase 1b dose escalation and expansion trial (n=69) shows a favorable safety profile, with manageable adverse events consistent with ...

Exelixis (NASDAQ:EXEL) remains focused on expanding its CABO franchise while preparing for potential launches and data ...

High-altitude environments, characterized by hypobaric hypoxia, intense ultraviolet radiation, and cold, are increasingly ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 9:00 AM EDTCompany ParticipantsAndrew Peters - Senior ...

A new therapy inspired by bacteria inside tumors cuts off cancer’s energy supply while largely leaving healthy cells ...

Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026: Rahway, New Jersey Wednesday, May 13, 2026, 11:00 Hrs [IST ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

The Australian government has shortlisted seven green hydrogen derivative projects, representing 2.18GW, for production ...